Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain.
about
sameAs
The level of recognition of physical symptoms in patients with a major depression episode in the outpatient psychiatric practice in Puerto Rico: an observational study.Pain and depression comorbidity: a preclinical perspective.Depressive symptoms and bodily pain: The role of physical disability and social stress.Effects of duloxetine treatment on brain response to painful stimulation in major depressive disorderSynthesis and evaluation of arylpiperazines derivatives of 3,5-dioxo-(2H,4H)-1,2,4-triazine as 5-HT1AR ligands.Raphe-Hippocampal Serotonin Neurotransmission In The Sex Related Differences of Adaptation to Stress: Focus on Serotonin-1A Receptor.Pathophysiology of depression and mechanisms of treatmentVilazodone for the treatment of major depressive disorder: focusing on its clinical studies and mechanism of action.Risk of psychiatric disorders following trigeminal neuralgia: a nationwide population-based retrospective cohort study.Association Between Depression and Acute Pain in Adults Attending a Tertiary Care Hospital in Bhubaneswar.Depression and posttraumatic stress disorder among women with vulvodynia: evidence from the population-based woman to woman health studyThe fibroblast growth factor family: neuromodulation of affective behavior.Functional polymorphisms of the brain serotonin synthesizing enzyme tryptophan hydroxylase-2.Antidepressant-like effects of lycii radicis cortex and betaine in the forced swimming test in rats.Estradiol potentiates 8-OH-DPAT-induced sumoylation of 5-HT₁A receptor: characterization and subcellular distribution of sumoylated 5-HT₁A receptors.Synthesis and in vivo evaluation of [(18)F]2-(4-(4-(2-(2-fluoroethoxy)phenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)-dione ([(18)F]FECUMI-101) as an imaging probe for 5-HT1A receptor agonist in nonhuman primates.OnabotulinumtoxinA effectiveness on chronic migraine, negative emotional states and sleep quality: a single-center prospective cohort study.Treatment of Functional GI Disorders With Psychotropic Medicines: A Review of Evidence With a Practical Approach.A regulatory domain in the N terminus of tryptophan hydroxylase 2 controls enzyme expression.Antidepressants as analgesics: an introduction
P2860
Q24810924-AE352118-C772-4CB4-B400-C2D2301B4622Q34438594-8643F48C-CAC6-4533-AC83-7BC119DD1622Q34607323-7BBE72D2-763A-4319-9F67-CF9BCA59BD25Q34660500-07A3EF02-1025-48BA-AB5C-24123E038DA8Q34960954-85AC1D41-9668-4998-9B8E-07194345C2FAQ35151893-630EFA8A-8DF2-4BFE-8E4B-CC55B5B45B37Q35236438-06A83501-8758-4E1B-B8ED-EDF8033A5313Q35330385-702E3737-8B0B-4614-BBE4-B98CE8AC5D94Q35850743-2F453D62-7287-4C60-A277-2A3550C2CF7FQ36068022-0A0514BE-86D3-49D1-9ACD-B07AC5C5EEDEQ36234718-17E8D3CD-3A4E-41F3-A761-DB24ABCFF1D4Q36334413-C0DF9C33-0F92-4B8C-99F3-0EB66BBB7BADQ36353771-EB341932-6757-42D3-8DA0-48017B7B4971Q37145472-5FFD31A2-B516-46E0-B232-B6006CF9EA24Q37230968-E47EBFD2-C83C-4E30-912C-EDF3E2C7E834Q37380723-74DC28E8-D7F9-4B4D-9D1C-B3129921E01EQ37650532-DFB9F524-FE99-424B-8C0A-474439036A5CQ37700196-448E11CF-DC01-489D-9DD6-CACA1043C08BQ39648339-9ACBCDBC-51CE-458C-813B-CEAD0274A861Q41847401-ADA79E85-E6B1-4C7C-B523-DE4B0D8AFF77
P2860
Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Putative mechanisms of action ...... and anxiety disorders and pain
@nl
Putative mechanisms of action ...... nd anxiety disorders and pain.
@ast
Putative mechanisms of action ...... nd anxiety disorders and pain.
@en
type
label
Putative mechanisms of action ...... and anxiety disorders and pain
@nl
Putative mechanisms of action ...... nd anxiety disorders and pain.
@ast
Putative mechanisms of action ...... nd anxiety disorders and pain.
@en
prefLabel
Putative mechanisms of action ...... and anxiety disorders and pain
@nl
Putative mechanisms of action ...... nd anxiety disorders and pain.
@ast
Putative mechanisms of action ...... nd anxiety disorders and pain.
@en
P2860
P1476
Putative mechanisms of action ...... and anxiety disorders and pain
@en
P2093
P2860
P407
P577
2001-01-01T00:00:00Z